Laser interstitial thermal therapy in older patients with drug‐resistant mesial temporal lobe epilepsy

OBJECTIVE: Laser interstitial thermal therapy (LITT) is a minimally invasive treatment for focal drug-resistant epilepsy (DRE). This study sought to examine the efficacy of LITT for a cohort of older adults with mesial temporal lobe epilepsy (MTLE) and evaluate predictors of safety. METHODS: We examined 24 patients aged ≥50 years, with 10/24 (42%) ≥60 years. Primary outcomes were Engel classification and reduction from baseline seizure frequency. We additionally reviewed post-ablation complications, hospital length of stay (LOS), neurocognitive and psychiatric worsening, and anti-seizure medication (ASM) reduction. The Charlson Comorbidity Index (CCI) was calculated to assess its utility in prediction of postoperative complications. RESULTS: 22/24 (92%) had ≥50% reduction in seizure frequency, and 17/24 (71%) had ≥90% reduction at last follow-up, with median follow-up of 5.2 years (range, 1.5-10.4 years). Engel Class I outcome was achieved in 19/24 (79%) of patients by 6 months post-ablation and maintained in 12/24 (50%) of patients by last follow-up. Immediate postoperative complications were mostly transient, though worse cognitive symptoms were reported in 5/24 (21%), and worse mood was reported in 3/24 (13%) at 6 months post-ablation. Higher CCI did not correlate with complications but was associated with prolonged LOS. ASM reduction occurred in half of patients. SIGNIFICANCE: In our cohort, LITT offered favorable seizure and safety outcomes in an older population with focal DRE. Perioperative risk assessments such as the CCI may be useful in older patient selection for LITT.

Authors

Institutions

Publication Details

Journal
Epileptic Disorders
Published
2026-11-16
DOI
https://doi.org/10.1002/epd2.70468
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Laser interstitial thermal therapy in older patients with drug‐resistant mesial temporal lobe epilepsy

Jessica J. Falco-Walter, Erica Leah Von Stein, Robert S. Fisher, Vivek Buch et al.
3 links
Epileptic Disorders
Epilepsy research and treatment
article

Laser interstitial thermal therapy in older patients with drug‐resistant mesial temporal lobe epilepsy

Jessica J. Falco-Walter, Erica Leah Von Stein, Robert S. Fisher, Vivek Buch, Ashwin G. Ramayya, David A. Hartmann, Scheherazade T. Le, Joanne Lau, Niyatee Samudra
article en

Abstract

OBJECTIVE: Laser interstitial thermal therapy (LITT) is a minimally invasive treatment for focal drug-resistant epilepsy (DRE). This study sought to examine the efficacy of LITT for a cohort of older adults with mesial temporal lobe epilepsy (MTLE) and evaluate predictors of safety. METHODS: We examined 24 patients aged ≥50 years, with 10/24 (42%) ≥60 years. Primary outcomes were Engel classification and reduction from baseline seizure frequency. We additionally reviewed post-ablation complications, hospital length of stay (LOS), neurocognitive and psychiatric worsening, and anti-seizure medication (ASM) reduction. The Charlson Comorbidity Index (CCI) was calculated to assess its utility in prediction of postoperative complications. RESULTS: 22/24 (92%) had ≥50% reduction in seizure frequency, and 17/24 (71%) had ≥90% reduction at last follow-up, with median follow-up of 5.2 years (range, 1.5-10.4 years). Engel Class I outcome was achieved in 19/24 (79%) of patients by 6 months post-ablation and maintained in 12/24 (50%) of patients by last follow-up. Immediate postoperative complications were mostly transient, though worse cognitive symptoms were reported in 5/24 (21%), and worse mood was reported in 3/24 (13%) at 6 months post-ablation. Higher CCI did not correlate with complications but was associated with prolonged LOS. ASM reduction occurred in half of patients. SIGNIFICANCE: In our cohort, LITT offered favorable seizure and safety outcomes in an older population with focal DRE. Perioperative risk assessments such as the CCI may be useful in older patient selection for LITT.

Epileptic Disorders
Stanford Medicine (US), Stanford University (US)
Good health and well-being
Epilepsy research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon